Alain van Gool

Radboud university medical center, EATRIS

Professor of Personalized Healthcare, Radboudumc; Chair of Biomarker Platform, EATRIS Alain van Gool is a professor of Personalized Healthcare at Radboud University Medical Center and an applied biomarker scientist at Netherlands Institute for Applied Scientific Research (TNO), with a strong passion in the application of biomarkers in translational medicine and personalized healthcare. His professional background since 1991 is a mix of academia, pharmaceutical industry, applied research institutes, university medical centers. He has been leading technology-based biomarker laboratories, cross-functional expert teams, therapeutic project teams and public-private consortia, many of which were focused on the discovery, development and implementation of translational biomarkers in a variety of therapeutic areas. While working in Europe, USA and Asia, he and his teams contributed to over 200 projects in various phases of biomarker R&D. His technical expertise resides most strongly in molecular profiling (various Omics approaches), analytical biomarker development, and applications in translational scientific research. Alain is a strong believer of open innovation networks and in his roles he has been collaborating with pharmaceutical, biotechnological, nutriceutical and diagnostic industries, SMEs, biobanks, clinicians, technology providers and information specialists to translate basic research to applied science through public-private partnerships. With that background, he currently heads the Radboudumc center for proteomics, glycomics & metabolomics, coordinates the Radboudumc Technology Centers, is Scientific Lead Technologies of DTL (the Dutch Techcenter for Life Sciences) and is chair Biomarker Platform of EATRIS (the European infrastructure for Translational Medicine) and is co-initiator of Health-RI (the Netherlands Personalized Medicine and Health Research Infrastructure), thus contributing to the organization and coordination of local, national and European technology infrastructures. Complementing his daily work, he enjoys contributing to several scientific advisory boards of start-up entrepreneurs, multinational companies, diagnostic organizations and conference organizers, and is part of several editorial boards of scientific journals.
Copyright 2017 © BCF GROUP. All rights reserved.